Braden Parker
Vermögen: 390 493 $ am 30.09.2026
Vermögen: 390 493 $ am 30.09.2026
Braden Parker is Chief Commercial Officer at Savara, Inc. since 2024.
Formerly, Mr. Parker was Chief Commercial Officer at Orchard Therapeutics Plc from 2021 to 2024 and Vice President & General Manager at PTC Therapeutics, Inc. from 2017 to 2020.
Education includes undergraduate studies at the University of Notre Dame and an MBA from The Leonard N Stern School of Business.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
SAVARA, INC. 0.04% | 24.09.2026 | 75’677 ( 0.04% ) | 390 493 $ | 30.09.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| SAVARA INC. | Corporate Officer/Principal | 24.09.2024 |
| Unternehmen | Position | Ende |
|---|---|---|
| ORCHARD THERAPEUTICS PLC | Corporate Officer/Principal | 01.02.2024 |
| PTC THERAPEUTICS, INC. | Corporate Officer/Principal | 01.03.2020 |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 5 |
|---|---|
PTC Therapeutics, Inc.
PTC Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets clinically differentiated medicines for neurodegenerative diseases | Health Technology |
University of Notre Dame
University of Notre Dame Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Leonard N Stern School of Business
The Leonard N Stern School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Savara, Inc.
Savara, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals to treat respiratory diseases | Health Technology |
Orchard Therapeutics Plc
Orchard Therapeutics Plc BiotechnologyHealth Technology Engages in research and advancements of gene therapy to develop potential cures for genetic & other severe diseases | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen